Triptolide inhibits interferon-γ-induced programmed death-1-ligand 1 surface expression in breast cancer cells

Cancer Letters

Volumn 270, Issue 2, 2008, Pages 337-341

  Liang, Mei ^a   Fu, Jian ^a  

^a UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

Author keywords

B7 H1; Breast cancer; Interferon; PD L1; Triptolide

Indexed keywords

CELL SURFACE PROTEIN; GAMMA INTERFERON; PROGRAMMED DEATH 1 LIGAND 1; TRIPTOLIDE; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER INHIBITION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; METASTASIS INHIBITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR IMMUNITY;

ANTIGENS, CD; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MEMBRANE; DITERPENES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; EPOXY COMPOUNDS; FEMALE; HUMANS; INTERFERON TYPE II; PHENANTHRENES; RECOMBINANT PROTEINS; TUMOR ESCAPE;

TRIPTERYGIUM WILFORDII;

EID: 52149116029     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2008.05.025     Document Type: Article

References (14)

1. Chen B.J. Triptolide, a novel immunosuppressive and anti-inflammatory agent purified from a Chinese herb Tripterygium wilfordii Hook F. Leuk. Lymphoma 42 (2001) 253-265
2. Kupchan S.M., Court W.A., Dailey Jr. R.G., Gilmore C.J., and Bryan R.F. Triptolide and tripdiolide, novel antileukemic diterpenoid triepoxides from Tripterygium wilfordii. J. Am. Chem. Soc. 94 (1972) 7194-7195
3. Chang W.T., Kang J.J., Lee K.Y., Wei K., Anderson E., Gotmare S., Ross J.A., and Rosen G.D. Triptolide and chemotherapy cooperate in tumor cell apoptosis. A role for the p53 pathway. J. Biol. Chem. 276 (2001) 2221-2227
4. Kiviharju T.M., Lecane P.S., Sellers R.G., and Peeh D.M. Antiproliferative and proapoptotic activities of triptolide (PG490), a natural product entering clinical trials, on primary cultures of human prostatic epithelial cells. Clin. Cancer Res. 8 (2002) 2666-2674
5. Phillips P.A., Dudeja V., McCarroll J.A., Borja-Cacho D., Dawra R.K., Grizzle W.E., Vickers S.M., and Saluja A.K. Triptolide induces pancreatic cancer cell death via inhibition of heat shock protein 70. Cancer Res. 67 (2007) 9407-9416
6. Yang S., Chen J., Guo Z., Xu X.M., Wang L., Pei X.F., Yang J., Underhill C.B., and Zhang L. Triptolide inhibits the growth and metastasis of solid tumors. Mol. Cancer Ther. 2 (2003) 65-72
7. Blank C., Gajewski T.F., and Mackensen A. Interaction of PD-L1 on tumor cells with PD-1 on tumor-specific T cells as a mechanism of immune evasion: implications for tumor immunotherapy. Cancer Immunol. Immunother. 54 (2005) 307-314
8. Dong H., Strome S.E., Salomao D.R., Tamura H., Hirano F., Flies D.B., Roche P.C., Lu J., Zhu G., Tamada K., Lennon C.V.A., Celis E., and Chen L. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat. Med. 8 (2002) 793-800
9. Iwai Y., Ishida M., Tanaka Y., Okazaki T., Honjo T., and Minato N. Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade. Proc. Natl. Acad. Sci. USA 99 (2002) 12293-12297
10. Cheng X., Zhao Z., Ventura E., Gran B., Shindler K.S., and Rostami A. The PD-1/PD-L pathway is up-regulated during IL-12-induced suppression of EAE mediated by IFN-gamma. J. Neuroimmunol. 185 (2007) 75-86
11. Liu J., Hamrouni A., Wolowiec D., Coiteux V., Kuliczkowski K., Hetuin D., Saudemont A., and Quesnel B. Plasma cells from multiple myeloma patients express B7-H1 (PD-L1) and increase expression after stimulation with IFN-gamma and TLR ligands via a MyD88-, TRAF6-, and MEK-dependent pathway. Blood 110 (2007) 296-304
12. Muhlbauer M., Fleck M., Schutz C., Weiss T., Froh M., Blank C., Scholmerich J., and Hellerbrand C. PD-L1 is induced in hepatocytes by viral infection and by interferon-alpha and -gamma and mediates T cell apoptosis. J. Hepatol. 45 (2006) 520-528
13. Zhang P., Su D.M., Liang M., and Fu J. Chemopreventive agents induce programmed death-1-ligand 1 (PD-L1) surface expression in breast cancer cells and promote PD-L1-mediated T cell apoptosis. Mol. Immunol. 45 (2008) 1470-1476
14. Nicolini A., Carpi A., and Rossi G. Cytokines in breast cancer. Cytokine Growth Factor Rev. 17 (2006) 325-337